Related Experiment Video
Updated: Jul 13, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Hyperhomocysteinemia and central retinal vein occlusion in Iranian population
Sasan Moghimi1, Zahra Najmi, Hooshang Faghihi
1Farabi Eye Research Center, Department of Ophthalmology, Tehran University of Medical Sciences, Quazvin Square, Tehran 1336616351, Iran. sasanimii@yahoo.com
Insights
Elevated total plasma homocysteine is an independent risk factor for central retinal vein occlusion (CRVO) in Iranians. Measuring homocysteine levels may aid in CRVO diagnosis and management.
Area of Science:
- Ophthalmology
- Cardiovascular Science
- Clinical Biochemistry
Background:
- Central retinal vein occlusion (CRVO) is a significant cause of vision loss.
- Hyperhomocysteinemia, an elevation in plasma homocysteine, is a potential risk factor for vascular diseases.
Purpose of the Study:
- To assess total plasma homocysteine levels in Iranian patients during the acute phase of CRVO.
- To determine if hyperhomocysteinemia is a risk factor for CRVO in this population.
Main Methods:
- A case-control study involving 54 patients with newly diagnosed CRVO and 51 matched controls.
- Fasting total plasma homocysteine levels were measured and compared between groups.
Main Results:
- Patients with CRVO had significantly higher mean total plasma homocysteine levels (14.76±7.67 µmol/l) compared to controls (11.42±3.74 µmol/l).
- Hyperhomocysteinemia was associated with an increased odds ratio for CRVO (OR=2.88, P=0.03), and levels above 15 µmol/l showed a higher adjusted odds ratio (OR=4.71, P=0.009).
- No significant difference in hyperhomocysteinemia prevalence was observed across different age groups.
Conclusions:
- Elevated total plasma homocysteine is an independent risk factor for CRVO in the Iranian population.
- Measuring total homocysteine levels should be considered in the initial evaluation and management of CRVO patients, alongside conventional cardiovascular risk factors.
Purpose:
To evaluate total plasma homocysteine level during the acute phase of central retinal vein occlusion (CRVO) in the Iranian population and determine whether hyperhomocysteinemia is also a risk factor for CRVO.
Methods:
Fifty-four patients with recently diagnosed CRVO were studied. Their fasting total plasma homocysteine level was compared with a matched control group of 51 patients evaluated in the same clinic for a non-retinal disease diagnosis.
Results:
The mean total plasma homocysteine level was 14.76+/-7.67 micromol/l in cases, and 11.42+/-3.74 micromol/l in control subjects. It showed a significant difference (P=0.005) in mean plasma homocysteine level between cases and control group. Odds ratio of CRVO for individuals with hyperhomocysteinemia was 2.88 (95% CI=1.08-7.71 and P=0.03). The overall multivariable-adjusted odds of CRVO in participants with plasma homocysteine level above 15 micromol/l was 4.71 (95% CI=1.46-15.19 and P=0.009) Hyperhomocysteinemia was not statistically different in each age group (<60 years: 27%, 61-70 years: 33.3%, 71-80 years: 31.6%, >81 years: 33.3%, Chi-square test, P=0.98).
Conclusion:
Elevated total plasma homocysteine level is an independent risk factor for CRVO in Iranian population. In addition to an evaluation of all conventional cardiovascular risk factors, measurement of total homocysteine for evidence of hyperhomocysteinemia may be important in the initial investigation and management of patients with CRVO.
Related Concept Videos
Diabetic Retinopathy
Glaucoma: Overview
Portal Hypertension
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
